Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Edwin Kepner Silverman, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Edwin Silverman and Matthew Moll.
Connection Strength

2.443
  1. A polygenic risk score and age of diagnosis of COPD. Eur Respir J. 2022 09; 60(3).
    View in: PubMed
    Score: 0.249
  2. Blood gene expression risk profiles and interstitial lung abnormalities: COPDGene and ECLIPSE cohort studies. Respir Res. 2022 Jun 17; 23(1):157.
    View in: PubMed
    Score: 0.245
  3. Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2022 01 15; 205(2):161-170.
    View in: PubMed
    Score: 0.238
  4. A systematic analysis of protein-altering exonic variants in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2021 07 01; 321(1):L130-L143.
    View in: PubMed
    Score: 0.226
  5. Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies. BMJ Open Respir Res. 2020 11; 7(1).
    View in: PubMed
    Score: 0.219
  6. Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts. Lancet Respir Med. 2020 07; 8(7):696-708.
    View in: PubMed
    Score: 0.214
  7. Machine Learning and Prediction of All-Cause Mortality in COPD. Chest. 2020 09; 158(3):952-964.
    View in: PubMed
    Score: 0.211
  8. The Association of Multiparity with Lung Function and Chronic Obstructive Pulmonary Disease-Related Phenotypes. Chronic Obstr Pulm Dis. 2020 Apr; 7(2):86-98.
    View in: PubMed
    Score: 0.210
  9. Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Respir Res. 2022 Apr 21; 23(1):97.
    View in: PubMed
    Score: 0.061
  10. Polygenic transcriptome risk scores for COPD and lung function improve cross-ethnic portability of prediction in the NHLBI TOPMed program. Am J Hum Genet. 2022 05 05; 109(5):857-870.
    View in: PubMed
    Score: 0.060
  11. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2022 02 01; 205(3):313-323.
    View in: PubMed
    Score: 0.060
  12. Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood. 2022 01 20; 139(3):357-368.
    View in: PubMed
    Score: 0.060
  13. Interaction of Cigarette Smoking and Polygenic Risk Score on Reduced Lung Function. JAMA Netw Open. 2021 12 01; 4(12):e2139525.
    View in: PubMed
    Score: 0.059
  14. Genetic Variation in the Mitochondrial Glycerol-3-Phosphate Acyltransferase Is Associated With Liver Injury. Hepatology. 2021 12; 74(6):3394-3408.
    View in: PubMed
    Score: 0.059
  15. Relationship Between Rheumatoid Arthritis and Pulmonary Function Measures on Spirometry in the UK Biobank. Arthritis Rheumatol. 2021 11; 73(11):1994-2002.
    View in: PubMed
    Score: 0.058
  16. Heterozygosity of the Alpha 1-Antitrypsin Pi*Z Allele and Risk of Liver Disease. Hepatol Commun. 2021 Aug; 5(8):1348-1361.
    View in: PubMed
    Score: 0.056
  17. A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study. Chronic Obstr Pulm Dis. 2020 Oct; 7(4):346-361.
    View in: PubMed
    Score: 0.054
  18. Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene. Eur Respir J. 2020 02; 55(2).
    View in: PubMed
    Score: 0.052
  19. COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis. 2019 Nov; 6(5):384-399.
    View in: PubMed
    Score: 0.051
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.